A031860 Stock Overview
SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
SU-Holdings Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,600.00 |
52 Week High | ₩12,880.00 |
52 Week Low | ₩1,500.00 |
Beta | 0.35 |
1 Month Change | -13.51% |
3 Month Change | -26.27% |
1 Year Change | -85.35% |
3 Year Change | -88.93% |
5 Year Change | -96.51% |
Change since IPO | -99.93% |
Recent News & Updates
Shareholder Returns
A031860 | KR Leisure | KR Market | |
---|---|---|---|
7D | 0% | 2.8% | 3.4% |
1Y | -85.3% | -17.5% | 7.1% |
Return vs Industry: A031860 underperformed the KR Leisure industry which returned -17.5% over the past year.
Return vs Market: A031860 underperformed the KR Market which returned 7.1% over the past year.
Price Volatility
A031860 volatility | |
---|---|
A031860 Average Weekly Movement | 16.5% |
Leisure Industry Average Movement | 4.0% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A031860's share price has been volatile over the past 3 months.
Volatility Over Time: A031860's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 25 | Moon-Wui Chung | su-holdings.com |
SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market. Its product is NEUROSONA, a treatment device for brain disease. The company was formerly known as NSN Co., Ltd.
SU-Holdings Co.,Ltd. Fundamentals Summary
A031860 fundamental statistics | |
---|---|
Market cap | ₩20.85b |
Earnings (TTM) | -₩31.73b |
Revenue (TTM) | ₩11.31b |
1.8x
P/S Ratio-0.7x
P/E RatioIs A031860 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A031860 income statement (TTM) | |
---|---|
Revenue | ₩11.31b |
Cost of Revenue | ₩9.47b |
Gross Profit | ₩1.84b |
Other Expenses | ₩33.57b |
Earnings | -₩31.73b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.44k |
Gross Margin | 16.24% |
Net Profit Margin | -280.60% |
Debt/Equity Ratio | 4.3% |
How did A031860 perform over the long term?
See historical performance and comparison